- Q3 2024 Resmed Inc Earnings Call TranscriptApr 25, 2024$183.42 (-0.20%)Earnings
- Q2 2024 Resmed Inc Earnings Call TranscriptJan 24, 2024$171.78 (-1.82%)Earnings
- Resmed Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Q1 2024 Resmed Inc Earnings Call TranscriptOct 26, 2023$138.73 (-1.26%)Earnings
- Resmed Inc at Bank of America Merrill Lynch Global Healthcare Conference TranscriptSep 14, 2023
- Resmed Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Q4 2023 Resmed Inc Earnings Call TranscriptAug 03, 2023$219.95 (-0.99%)Earnings
- Resmed Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Q3 2023 Resmed Inc Earnings Call TranscriptApr 27, 2023$225.3 (+0.62%)Earnings
- Resmed Inc at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum (Virtual) TranscriptMar 21, 2023
- Resmed Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 13, 2023
- Q2 2023 Resmed Inc Earnings Call TranscriptJan 26, 2023$232.17 (+0.44%)Earnings
- Resmed Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Q1 2023 Resmed Inc Earnings Call TranscriptOct 27, 2022$232.29 (-0.72%)Earnings
- Resmed Inc at Bank of America Merrill Lynch Global Healthcare Conference TranscriptSep 14, 2022
- Resmed Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q4 2022 Resmed Inc Earnings Call TranscriptAug 11, 2022$240.85 (-1.12%)Earnings
- Resmed Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 14, 2022
- Resmed Inc to Acquire Medifox Dan GmbH Call TranscriptJun 14, 2022
- Resmed Inc at William Blair Growth Stock Conference TranscriptJun 08, 2022
- Resmed Inc at Sanford C Bernstein Strategic Decisions Conference TranscriptJun 01, 2022
- Resmed Inc at Macquarie Australia Conference TranscriptMay 02, 2022
- Q3 2022 Resmed Inc Earnings Call TranscriptApr 28, 2022$213.51 (-0.56%)Earnings
- Resmed Inc at KeyBanc Capital Markets Life Sciences & MedTech Forum (Virtual) TranscriptMar 22, 2022
- Resmed Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 15, 2022
- Resmed Inc at Citi Healthcare Conference (Virtual) TranscriptFeb 23, 2022
- Q2 2022 Resmed Inc Earnings Call TranscriptJan 27, 2022$224.89 (-2.66%)Earnings
- Resmed Inc at J.P. Morgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Resmed Inc at Goldman Sachs Healthcare CEOs Unscripted Conference: A View from the Top (Virtual) TranscriptJan 06, 2022
- Resmed Inc Annual Shareholders Meeting TranscriptNov 18, 2021
- Resmed Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 10, 2021
- Q1 2022 Resmed Inc Earnings Call TranscriptOct 28, 2021$268.66 (+0.20%)Earnings
- Resmed Inc at Bank of America Global Healthcare Conference (Virtual) TranscriptSep 15, 2021
- Resmed Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 09, 2021
- Resmed Inc Investor Day TranscriptSep 08, 2021
- Q4 2021 Resmed Inc Earnings Call TranscriptAug 05, 2021$267.38 (-2.13%)Earnings
- Resmed Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- Resmed Inc at William Blair Growth Stock Conference (Virtual) TranscriptJun 01, 2021
- Resmed Inc at Macquarie Australia Conference (Virtual) TranscriptMay 04, 2021
- Q3 2021 Resmed Inc Earnings Call TranscriptApr 29, 2021$207.91 (-1.06%)Earnings
- Resmed Inc at KeyBanc Capital Markets Life Sciences & Medtech Investor Forum (virtual) TranscriptMar 23, 2021
- Q2 2021 Resmed Inc Earnings Call TranscriptJan 28, 2021$215.93 (+0.87%)Earnings
- Resmed Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Resmed Inc Annual Shareholders Meeting TranscriptNov 19, 2020
- Resmed Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 10, 2020
- Q1 2021 Resmed Inc Earnings Call TranscriptOct 29, 2020$179.51 (-0.64%)Earnings
- Resmed Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Q4 2020 Resmed Inc Earnings Call TranscriptAug 05, 2020$202.96 (+0.09%)Earnings
- Resmed Inc at William Blair Growth Stock Conference TranscriptJun 10, 2020
- Resmed Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 12, 2020
- Q3 2020 Resmed Inc Earnings Call TranscriptApr 30, 2020$155.32 (-0.63%)Earnings
- Q2 2020 Resmed Inc Earnings Call TranscriptJan 30, 2020$165.44 (-0.24%)Earnings
- Resmed Inc at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Resmed Inc at Credit Suisse Healthcare Conference - Scottsdale TranscriptNov 12, 2019
- Q1 2020 Resmed Inc Earnings Call TranscriptOct 24, 2019$127.73 (+0.78%)Earnings
- Resmed Inc at Bank of America Merrill Lynch Global Healthcare Conference TranscriptSep 19, 2019
- Resmed Inc at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Q4 2019 Resmed Inc Earnings Call TranscriptJul 25, 2019$123.84 (-1.29%)Earnings
- Resmed Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 11, 2019
- Resmed Inc at William Blair Growth Stock Conference TranscriptJun 06, 2019
- Q3 2019 Resmed Inc Earnings Call TranscriptMay 02, 2019$105.74 (+1.24%)Earnings
- Resmed Inc Investor Meeting TranscriptApr 04, 2019
- Q2 2019 Resmed Inc Earnings Call TranscriptJan 24, 2019$117.3 (+0.07%)Earnings
Resmed Inc at Macquarie Australia Conference Transcript
Good morning, everyone. My name is David Bailey, I'm part of the healthcare team at Macquarie. Today's format will be a short introduction, followed by a Q&A session. If you do wish to submit a question, you can do so via the app. Moving on. It's my pleasure to introduce you to Brett Sandercock this morning, CFO of ResMed. Brett, perhaps we can start with some introductory comments in relation to your most recent results, and then we'll jump into Q&A from there.
Sure. Thanks, David. It's a real pleasure to join you this morning and hello, everyone. So what I thought I might do is just briefly recap on our Q3 results and just run through that with a few of the highlights there. So Q3 -- had a pretty solid performance in Q3. We had revenue growth of 14%. And of course, we were impacted by ongoing supply constraints and that definitely limited our ability to really supply and meet pretty unprecedented demand in the marketplace at the moment due to the Philips recall. So we
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)